The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Investing Trends and Worries at Future Proof in California
39:49

NYC's Lincoln Center Aims To Bring World Class Art To Everyone
11:25

Global AI Supercycle Raises Productivity Questions
41:36